Zambon
Alfonso Zambon, Surrey GB
Patent application number | Description | Published |
---|---|---|
20100298320 | Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds for treating proliferative disorders, cancer, etc., and more specifically to certain pyrido[2,3-b]pyrazin-8-substituted compounds, as described herein, which, inter alia, inhibit RAF (e.g., B-RAF) activity. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit RAF (e.g., BRAF) activity, to inhibit receptor tyrosine kinase (RTK) activity, to inhibit cell proliferation, and in the treatment of diseases and disorders that are ameliorated by the inhibition of RAF, RTK, etc., proliferative disorders such as cancer (e.g., colorectal cancer, melanoma), etc. | 11-25-2010 |
20110053946 | Aryl-Quinolyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds for treating proliferative disorders, cancer, etc., and more specifically to certain aryl-quinolyl compounds, as described herein, which, inter alia, inhibit RAF (e.g., B-RAF) activity. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit RAF (e.g., BRAF) activity, to inhibit receptor tyrosine kinase (RTK) activity, to inhibit cell proliferation, and in the treatment of diseases and disorders that are ameliorated by the inhibition of RAF, RTK, etc., proliferative disorders such as cancer (e.g., colorectal cancer, melanoma), etc. | 03-03-2011 |
Alfonso Zambon, Venezia IT
Patent application number | Description | Published |
---|---|---|
20110112110 | ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF - Inhibitors of the oncogenic tyrosine kinase ALK and of the Bcr-Abl mutant T315I Bcr-Abl, pharmaceutical compositions containing the same and their use for the treatment of hyper-proliferative diseases. | 05-12-2011 |
Alfonso Zambon, Sutton GB
Patent application number | Description | Published |
---|---|---|
20120238568 | Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds for treating proliferative disorders, cancer, etc., and more specifically to certain pyrido[2,3-b]pyrazin-8-substituted compounds, as described herein, which, inter alia, inhibit RAF (e.g., B-RAF) activity. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit RAF (e.g., BRAF) activity, to inhibit receptor tyrosine kinase (RTK) activity, to inhibit cell proliferation, and in the treatment of diseases and disorders that are ameliorated by the inhibition of RAF, RTK, etc., proliferative disorders such as cancer (e.g., colorectal cancer, melanoma), etc. | 09-20-2012 |
20120283288 | 1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUORO-4-(1-METHYL-2-OXO-2,- 3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-UREA AND RELATED COMPOUNDS AND THEIR USE IN THERAPY - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain compounds of the following formula (I) (for convenience, collectively referred to herein as “IP compounds”), which, inter alia, are useful in the treatment of cancer, e.g., cancer characterised by (e.g., driven by) mutant RAS (“mutant RAS cancer”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions in the treatment of cancer, e.g., mutant RAS cancer. | 11-08-2012 |
20140121212 | Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds for treating proliferative disorders, cancer, etc., and more specifically to certain pyrido[2,3-b]pyrazin-8-substituted compounds, as described herein, which, inter alia, inhibit RAF (e.g., B-RAF) activity. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit RAF (e.g., BRAF) activity, to inhibit receptor tyrosine kinase (RTK) activity, to inhibit cell proliferation, and in the treatment of diseases and disorders that are ameliorated by the inhibition of RAF, RTK, etc., proliferative disorders such as cancer (e.g., colorectal cancer, melanoma), etc. | 05-01-2014 |
20140357663 | 1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUORO-4-(1-METHYL-2-OXO-2,- 3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-UREAAND RELATED COMPOUNDS AND THEIR USE IN THERAPY - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain compounds of the following formula (for convenience, collectively referred to herein as “IP compounds”), which, inter alia, are useful in the treatment of cancer, e.g., cancer characterised by (e.g., driven by) mutant RAS (“mutant RAS cancer”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions in the treatment of cancer, e.g., mutant RAS cancer. | 12-04-2014 |
Carina Zambon, Mougins FR
Patent application number | Description | Published |
---|---|---|
20120175422 | RADIO FREQUENCY IDENTIFICATION DEVICE IN POLYCARBONATE AND ITS MANUFACTURING METHOD - The invention concerns a method for manufacturing a radio frequency identification device (RFID), featuring a flat and flexible substrate made of polycarbonate equipped with an antenna ( | 07-12-2012 |
Elisa Zambon, Fiumicello IT
Patent application number | Description | Published |
---|---|---|
20140329232 | METHOD FOR THE DETECTION OF NUCLEIC ACID SYNTHESIS AND/OR AMPLIFICATION - The present invention relates to a method for the detection of nucleic acid synthesis and/or amplification, characterised in that the method includes adding at least one colorimetric metal indicator and at least one bland magnesium chelator to a reaction mixture for nucleic acid amplification. The present invention further relates to a kit for carrying out such a method and to the use thereof in the health, food and agricultural or veterinary fields. | 11-06-2014 |
Emmanuele Zambon, Enschede NL
Patent application number | Description | Published |
---|---|---|
20140090054 | System and Method for Detecting Anomalies in Electronic Documents - A system and method are described herein for detecting an anomaly in an electronic document. In a computer system, a detection engine is attached to an application program which processes the electronic document. Function calls to a service provided through an application program interface (API) are intercepted by the detection engine as the application program processes the electronic document. If an entry for the intercepted function call is not present in the detection model, or an entry is present but the argument value does not match the argument value in the detection model, an alert is raised. The detection model is populated by processing a plurality of known good documents, populating the detection model with entries on intercepted good function calls and their argument values. A threshold may be applied to the detection model, removing from the detection model function calls which were observed less than the threshold amount. | 03-27-2014 |
20140297572 | METHOD AND SYSTEM FOR CLASSIFYING A PROTOCOL MESSAGE IN A DATA COMMUNICATION NETWORK - An intrusion detection method for detecting an intrusion in data traffic on a data communication network parses the data traffic to extract at least one protocol field of a protocol message of the data traffic, and associates the extracted protocol field with a model for that protocol field. The model is selected from a set of models. An assessment is made to determine if a contents of the extracted protocol field is in a safe region as defined by the model, and an intrusion detection signal is generated in case it is established that the contents of the extracted protocol field is outside the safe region. The set of models may comprise a corresponding model for each protocol field of a set of protocol fields. | 10-02-2014 |
Ivan Zambon, Alessandria IT
Patent application number | Description | Published |
---|---|---|
20130306890 | VALVE ASSEMBLY, IN PARTICULAR FOR USE IN PNEUMATIC NETWORKS - A valve assembly for use in a pneumatic network, includes a body having a first inlet port and a first air discharge port. A main duct includes a convergent portion, a restricted-section portion having a variable area of passage, and a divergent portion. An actuator assembly includes an intake volume and a second inlet port in fluid communication with the intake volume by valve means provided for enabling intake of a second fluid flow through the second inlet port and towards the intake volume, wherein the second fluid flow is drained off through the first discharge port together with the first fluid flow. | 11-21-2013 |
Nathan Zambon, Eagan, MN US
Patent application number | Description | Published |
---|---|---|
20100170234 | Injector Mounting Configuration for an Exhaust Treatment System - The present disclosure relates to a device for mounting an injector to an exhaust pipe. The device includes an injector mounting structure having an exterior surface configured for mounting the injector. The injector mounting structure also includes an interior surface arrangement defining an interior volume and a port for allowing the injector to inject a reductant into the interior volume. The interior surface arrangement is configured to prevent swirling of exhaust within the interior volume. | 07-08-2010 |
20150047329 | INJECTOR MOUNTING CONFIGURATION FOR AN EXHAUST TREATMENT SYSTEM - The present disclosure relates to a device for mounting an injector to an exhaust pipe. The device includes an injector mounting structure having an exterior surface configured for mounting the injector. The injector mounting structure also includes an interior surface arrangement defining an interior volume and a port for allowing the injector to inject a reductant into the interior volume. The interior surface arrangement is configured to prevent swirling of exhaust within the interior volume. | 02-19-2015 |
Paolo Zambon, Campbell, CA US
Patent application number | Description | Published |
---|---|---|
20140248048 | SIMPLE LOW COST TIP-TILT WAVEFRONT SENSOR HAVING EXTENDED DYNAMIC RANGE - A low cost, high reliability system for correcting aberrations in optical signals is disclosed. A foreoptic assembly, such as a telescope, receives an incoming optical signal and directs it to an active optical element, such as a fast steering mirror. The incoming optical signal is diffracted by a diffractive optical element to shape the image that is formed at a wavefront sensor, such as a quad-cell. The wavefront sensor measures a tip-tilt aberration of the incoming optical signal and the active optical element is adjusted to correct the measured aberration. An outgoing optical signal can be transmitted along substantially the same optical path as the incoming optical signal, but in the opposite direction. Thus, the aberration measured from the incoming optical signal can be automatically accounted for in the outgoing optical signal. | 09-04-2014 |
Paulo Zambon, Campbell, CA US
Patent application number | Description | Published |
---|---|---|
20140166632 | Dual-loop control for laser annealing of semiconductor wafers - Systems and methods for performing semiconductor laser annealing using dual loop control are disclosed. The first control loop operates at a first frequency and controls the output of the laser and controls the 1/f laser noise. The second control loop also controls the amount of output power in the laser and operates at second frequency lower than the first frequency. The second control loop measures the thermal emission of the wafer over an area the size of one or more die so that within-die emissivity variations are average out when determining the measured annealing temperature. The measured annealing temperature and an annealing temperature set point are used to generate the control signal for the second control loop. | 06-19-2014 |
Robert A. Zambon, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20080262633 | Cancellous bone treated with collagenase and essentially free of blood cells - A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying out their osteogenic function and to provide for an increased rate of bone formation. Such implant also may include demineralized bone, such as demineralized cortical bone, which enhances the bone regenerative capacity of the cancellous bone. | 10-23-2008 |
Sergio Zambon, Piracicaba BR
Patent application number | Description | Published |
---|---|---|
20130203597 | Use of Strobilurins for Increasing the Gluten Strength in Winter Cereals - The present invention relates to the use of a strobilurin (compound A) selected from the group consisting of pyraclostrobin, azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyribencarb, trifloxystrobin, pyrametostrobin, pyraoxystrobin, coumoxystrobin, coumethoxystrobin, triclopyricarb (chlorodincarb), fenaminstrobin (diclofenoxystrobin), fenoxystrobin, 2-(2-(6-(3-chloro-2-methyl-phenoxy)-5-fluoro-pyrimidin-4-yloxy)-phenyl)-2-methoxyimino-N-methyl-acetamide, 3-methoxy-2-(2-(N-(4-methoxy-phenyl)-cyclopropane-carboximidoylsulfanylmethyl)-phenyl)-acrylic acid methyl ester, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methyl-acetamide for increasing the gluten strength in winter cereals. | 08-08-2013 |
20140106966 | Fungicidal mixtures based on carbamate derivatives and insecticides - The present invention relates to mixtures comprising as active components | 04-17-2014 |
Sergio Zambon, Imigrantes BR
Patent application number | Description | Published |
---|---|---|
20080287293 | Pesticidal Mixtures - Pesticidal mixtures comprising, as active components, | 11-20-2008 |
Stefano Zambon, Dueville (vi) IT
Patent application number | Description | Published |
---|---|---|
20150068390 | SYSTEM TO REPRODUCE THE SOUND OF A STRINGED INSTRUMENT - A system used to reproduce the sound of a stringed instrument provided with hammers striking the strings is disclosed. The system comprises speed detection means coupled with each hammer to detect the percussion velocity on the string, a plurality of note modules receiving in input a signal representative of the hammer velocity and generating a force signal (F | 03-12-2015 |